High-Risk Diagnosis in Pregnancy with Multinodular Toxic Goiter
A pregnant woman with multinodular toxic goiter faces multiple high-risk diagnoses including maternal thyrotoxicosis complications (preterm delivery, pre-eclampsia, congestive heart failure, fetal death), potential fetal hyperthyroidism from transplacental antibody passage, and acute airway obstruction from goiter enlargement—all requiring immediate assessment and aggressive management.
Maternal Complications from Inadequately Treated Hyperthyroidism
The primary high-risk diagnosis is inadequately controlled maternal thyrotoxicosis, which carries severe consequences. According to the Endocrine Society guidelines, untreated maternal hyperthyroidism significantly increases risk of 1:
- Medically indicated preterm delivery
- Intrauterine growth restriction and low birth weight
- Pre-eclampsia
- Congestive heart failure
- Fetal death
These risks are directly related to the severity and duration of uncontrolled thyrotoxicosis, making prompt diagnosis and treatment essential.
Fetal Hyperthyroidism Risk
Fetal hyperthyroidism from transplacental passage of TSH receptor antibodies (TRAb) represents another critical high-risk diagnosis, though rare (0.01% of pregnancies). This should be considered in any woman with current or past Graves' disease 1. Maternal TRAb levels exceeding three times the upper normal limit can induce fetal hyperthyroidism, which manifests as:
- Intrauterine growth restriction
- Fetal tachycardia
- Fetal goiter
- Advanced bone age
- Fetal hydrops
- Preterm delivery
- Fetal death
Important caveat: While the guidelines focus on Graves' disease (which accounts for 85% of hyperthyroidism in pregnancy), multinodular toxic goiter can also cause maternal thyrotoxicosis with similar maternal and fetal complications, though TRAb-mediated fetal hyperthyroidism is less likely 1.
Acute Airway Obstruction
Acute respiratory compromise from goiter enlargement is an underrecognized but potentially life-threatening high-risk diagnosis specific to multinodular goiter in pregnancy. Pregnancy has goitrogenic effects that can cause rapid thyroid enlargement 2, 3, 4, 5, 6. Case reports document:
- Acute severe ventilatory failure initially misdiagnosed as asthma 2
- Hemorrhagic enlargement causing upper airway obstruction 4, 6
- Tracheal compression requiring urgent thyroidectomy even during pregnancy 4, 5
This complication can occur suddenly, even in previously stable goiters, and may be triggered by intrathyroidal hemorrhage 6.
Treatment-Related Iatrogenic Risks
Iatrogenic fetal hypothyroidism from antithyroid drug overtreatment is another high-risk diagnosis to monitor. The guidelines emphasize that while undertreatment causes the maternal/fetal complications listed above, overtreatment with thioamides can result in fetal hypothyroidism 1. Additionally, undertreatment may lead to central congenital hypothyroidism 1.
Malignancy Risk Consideration
While not the primary concern in toxic goiter, incidental thyroid malignancy should be considered. Recent data shows malignancy in approximately 21% of toxic nodular goiter cases, with toxic multinodular goiter and male gender being significant predictors 7. However, during pregnancy, fine-needle biopsy is only recommended for EU-TIRADS 5 nodules >1 cm or suspicious lymphadenopathy in the first half of pregnancy 8.
Essential Diagnostic Workup
For any pregnant woman with multinodular toxic goiter, immediately measure 1:
- Serum TSH (interpret with pregnancy-specific ranges—normally suppressed in first trimester)
- Free T4 or total T4
- Total T3
- TRAb levels (to assess fetal hyperthyroidism risk)
Clinical examination must specifically assess for:
- Goiter with bruit or thrill (suggests Graves' disease)
- Signs of respiratory compromise (stridor, dyspnea, orthopnea)
- Symptoms of thyrotoxicosis beyond normal pregnancy symptoms
Management Priority Algorithm
The treatment approach depends on disease severity and trimester 1, 8:
For symptomatic hyperthyroidism requiring treatment:
- First trimester: Use propylthiouracil (PTU) to avoid methimazole embryopathy
- Second/third trimester: Switch to methimazole to avoid PTU hepatotoxicity
- Target maternal free T4 at upper limit of normal (1.5-2× ULN) to prevent fetal hypothyroidism
- Fetal ultrasound monitoring from 22 weeks for signs of fetal hypothyroidism (goiter)
For respiratory symptoms:
- Beta-blockers (metoprolol) for symptomatic relief 1, 8
- Urgent imaging if acute airway compromise suspected
- Thyroidectomy in second trimester if airway threatened—surgery should not be delayed if mother's prognosis is at risk 8, 4
Critical pitfall: Do not dismiss respiratory symptoms as normal pregnancy dyspnea or asthma—acute goiter enlargement can cause life-threatening airway obstruction requiring emergency intervention 2, 4.